Miroslawa Nowak

De novo <i>CIAS1</i> mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseases

Ivona Aksentijevich, Miroslawa Nowak, Mustapha Mallah et al. · Arthritis & Rheumatism · 2002 · 703 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Anti–<i>N</i>‐methyl‐<scp>D</scp>‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus

Larissa Lapteva, Miroslawa Nowak, Cheryl Yarboro et al. · Arthritis & Rheumatism · 2006 · 259 citations

Medicine, Neurology, Psychiatry +17

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis

Philip J. Mease, Atul Deodhar, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2022 · 204 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus

Tresa Roebuck‐Spencer, Cheryl Yarboro, Miroslawa Nowak et al. · Arthritis Care & Research · 2006 · 74 citations

Medicine, Psychiatry, Psychology +17

De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases

Donald Goldsmith, Hal M. Hoffman, John J. O’Shea et al. · UNC Libraries · 2020 · 73 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17